Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.

Authors:
T Yamamoto
T Yamamoto
Nippon Veterinary and Life Science University
Japan
K Tsuji
K Tsuji
Keio University
Japan

Br J Dermatol 2015 Jan 10;172(1):56-63. Epub 2014 Dec 10.

Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Background: Epstein-Barr virus (EBV)-associated T/natural-killer lymphoproliferative disorders form a group of diseases that includes classical and systemic hydroa vacciniforme (HV) and hypersensitivity to mosquito bites (HMB). Patients with systemic HV (sHV) and HMB often have a poor prognosis, although little is known about the prognostic factors.

Objectives: To elucidate the prognostic factors of HV and HMB.

Methods: We studied clinicopathological manifestations, routine laboratory findings, anti-EBV titres, EBV DNA load and EBV-encoded gene expression, including expression of BZLF1, in 50 patients with classical HV (cHV), sHV, HMB only and HMB with HV (HMB + HV), and further analysed 30 patients who were available for follow-up.

Results: The median age of disease onset was 5 years (range 1-74). A follow-up study indicated that fatal outcomes were observed in three of eight patients with sHV, two of six patients with HMB only, and two of five patients with HMB + HV. The main causes of death were complications from haematopoietic stem-cell transplantation and multiorgan failure. There were no fatalities among the 11 patients with cHV. Univariate analysis revealed two poor prognostic indicators: (i) onset age > 9 years and (ii) the expression of an EBV-encoded immediate-early gene transcript, BZLF1 mRNA, in the skin lesions (P < 0·001 and P = 0·003, respectively).

Conclusions: No prognostic correlation was observed in EBV-infected lymphocyte subsets, anti-EBV antibody titres or EBV DNA load. Late onset and EBV reactivation are both related to more severe phenotypes of the disease, and thus may predict a poor prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.13411DOI Listing
January 2015
6 Reads

Publication Analysis

Top Keywords

hydroa vacciniforme
8
vacciniforme hypersensitivity
8
hypersensitivity mosquito
8
mosquito bites
8
shv hmb
8
hmb patients
8
prognostic factors
8
patients
7
hmb
5
patients hmb
4
laboratory findings
4
patients hmb + hv
4
routine laboratory
4
findings anti-ebv
4
anti-ebv titres
4
ebv dna
4
three patients
4
titres ebv
4
patients shv
4
shv patients
4

Similar Publications

Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.

J Dermatol Sci 2016 Jun 5;82(3):153-9. Epub 2016 Mar 5.

Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan. Electronic address:

Background: Epstein-Barr virus (EBV)-associated T/natural killer (NK)-lymphoproliferative disorders (LPDs) include hydroa vacciniforme (HV) and hypersensitivity to mosquito bites (HMB). The pathomechanisms of these diseases are still unclear.

Objective: To understand the inflammatory process, we examined EBV reactivation markers, BZLF1 and BDRF1 mRNA in the tissue and blood from patients with EBV-associated T/NK-LPDs. Read More

View Article
June 2016

Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.

J Invest Dermatol 2012 May 2;132(5):1401-8. Epub 2012 Feb 2.

Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kawasaki Medical School, Okayama, Japan.

Hydroa vacciniforme (HV) is a rare photosensitivity disorder of childhood associated with Epstein-Barr virus (EBV)(+) T-cell infiltration. We have summarized clinical manifestations of HV, and analyzed EBV(+) T-cell subsets as well as EBV DNA load in lymphocyte fractions, in comparison with hypersensitivity to mosquito bites (HMB), an EBV-associated T/natural killer (NK) lymphoproliferative disorder. We found that 31 of 33 (93. Read More

View Article
May 2012

Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.

Arch Dermatol 2006 May;142(5):587-95

Departments of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

Objectives: To determine the pathogenic association of latent Epstein-Barr virus (EBV) infections with both typical hydroa vacciniforme (HV) and severe HV-like eruptions, and to survey the complications and outcomes of patients.

Design: Case series.

Patients: Twenty-nine patients with HV or severe HV-like eruptions. Read More

View Article
May 2006

A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.

J Microbiol Methods 2007 Feb 1;68(2):403-7. Epub 2006 Dec 1.

Department of Dermatology, Okayama University School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

Objective: To establish a new diagnostic method for Epstein-Barr virus (EBV)-associated cutaneous disorders.

Design: Skin biopsy is usually required to confirm the latent EBV infections in cutaneous lesions of EBV-associated NK/T-cell lymphoproliferative disorders, including hydroa vacciniforme (HV) and hypersensitivity to mosquito bites (HMB). We have devised a novel, noninvasive method to detect EBV-encoded small RNA (EBER), BamHI A rightward transcripts (BARTs) in the skin crusts and scales of such patients. Read More

View Article
February 2007